Senior Vice President, Chief Financial Officer · MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Marc Schneebaum

A named executive officer of MADRIGAL PHARMACEUTICALS in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$2,940,472

Salary $435,000Stock awards $0

FY2019: $3,532,652

5th of 5 named executive officers at Madrigal Pharmaceuticals by FY2020 total.

5 named officers on file for MADRIGAL PHARMACEUTICALS, FY2020

Marc Schneebaum’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • MDGL’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how MADRIGAL PHARMACEUTICALS’s whole pay program stands against its peers

  • MADRIGAL PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MDGL→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2021 (DEF 14A).

Free

Get Marc Schneebaum’s full pay file as a PDF — free

More than this page: up to 10 years of Marc’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Marc Schneebaum compensation by year

MADRIGAL PHARMACEUTICALS Summary Compensation Table · all 5 fiscal years held
In US dollars, as MADRIGAL PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$365,000$365,000$380,250$421,000$435,000
Bonus$0$0$0$0$0
Stock awards$393,753$0$0$0$0
Option awards$729,135$346,437$2,748,200$2,868,320$2,219,840
Non-equity incentive$146,487$244,550$222,314$223,298$267,233
Pension and deferred compensation$0$0$0$0$0
All other$51,247$14,307$15,336$20,034$18,399
Total$1,685,622$970,294$3,366,100$3,532,652$2,940,472

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MADRIGAL PHARMACEUTICALS, INC. DEF 14A filed April 30, 2021, accession 0001193125-21-144922, and prior-year filings. Open the filing on EDGAR.

How this page was built: the MADRIGAL PHARMACEUTICALS, INC. filed document, accession 0001193125-21-144922. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2021.

$1.7M
$970K
$3.4M
$3.5M
$2.9M
FY16
FY17
FY18
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option8,750—$124.45
Option32,000—$91.79
Option1,706—$15.80
Option15,750—$127.96

Per the Outstanding Equity Awards at Fiscal Year-End table in MADRIGAL PHARMACEUTICALS, INC.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

MADRIGAL PHARMACEUTICALS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Paul FriedmanChairman and Chief Executive Officer$4,535,446
Brian LynchSenior Vice President and General Counsel$4,447,893
Rebecca TaubPresident, Research & Development and Chief Medical Officer$3,882,343
Remy SukhijaSenior Vice President, Chief Commercial Officer$3,438,902
Marc Schneebaum · this pageSenior Vice President, Chief Financial Officer$2,940,472

The full MADRIGAL PHARMACEUTICALS compensation record

free company brief

This page is one person within MADRIGAL PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the MADRIGAL PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MADRIGAL PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Marc Schneebaum's compensation dossier · One-time report. No refunds.